Hall F Scott, Goeb Michelle, Li Xiao-Fei, Sora Ichiro, Uhl George R
Molecular Neurobiology Branch, National Institute on Drug Abuse-IRP, NIH/DHHS, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA.
Brain Res Mol Brain Res. 2004 Feb 5;121(1-2):123-30. doi: 10.1016/j.molbrainres.2003.10.024.
The mu-opioid receptor (OPRM1) is expressed in brain regions implicated in reward and locomotor processes. Reduced reward, not only from opiates, but also from several other abused substances has been observed in mice with lifelong deletions of the OPRM1 gene. To further define the roles of mu-opioid receptors in psychostimulant actions, cocaine psychomotor stimulant and rewarding effects were examined in wild-type (WT), heterozygous and homozygous mu-opioid receptor knockout mice. While mu-opioid receptor knockout did not affect basal locomotion, locomotor stimulant effects of cocaine were enhanced in a within-subjects dose-response experiment. However, further study revealed that in mice injected with 20 mg/kg for the first time, there was no difference in the locomotor-stimulating effects of cocaine between knockout and wild-type mice. In a sensitization study (modeled after the conditions in the dose-response experiment) although not observed in WT mice, OPRM1-/- mice did exhibit cocaine sensitization. By stark contrast, and similar to the effects of other rewarding drugs in OPRM1 KO mice, cocaine reward, as assessed by conditioned place preference, was reduced in both homozygous and heterozygous OPRM1 KO mice. The present results confirm a central role of the mu-opioid receptor in drug reward but opposing effects on locomotor sensitization. The reduced cocaine reward identified in heterozygous mu-opioid receptor knockout mice supports the possibility that humans with fewer available mu-opioid receptors might experience less cocaine reward.
μ-阿片受体(OPRM1)在与奖赏和运动过程相关的脑区中表达。在OPRM1基因终身缺失的小鼠中,不仅观察到阿片类药物导致的奖赏减少,还发现其他几种滥用物质也会导致奖赏减少。为了进一步明确μ-阿片受体在精神兴奋剂作用中的作用,我们在野生型(WT)、杂合子和纯合子μ-阿片受体敲除小鼠中研究了可卡因的精神运动兴奋和奖赏效应。虽然μ-阿片受体敲除不影响基础运动,但在一项受试者内剂量反应实验中,可卡因的运动兴奋效应增强。然而,进一步研究发现,首次注射20mg/kg可卡因时,敲除小鼠和野生型小鼠之间的运动刺激效应没有差异。在一项致敏研究中(模拟剂量反应实验的条件),虽然野生型小鼠未观察到,但OPRM1-/-小鼠确实出现了可卡因致敏。与之形成鲜明对比的是,与OPRM1基因敲除小鼠中其他奖赏药物的作用类似,通过条件性位置偏爱评估的可卡因奖赏在纯合子和杂合子OPRM1基因敲除小鼠中均降低。目前的结果证实了μ-阿片受体在药物奖赏中起核心作用,但对运动致敏有相反的影响。在杂合子μ-阿片受体敲除小鼠中发现的可卡因奖赏减少支持了这样一种可能性,即具有较少可用μ-阿片受体的人可能体验到较少的可卡因奖赏。